DBVT

DBVT

USD

DBV Technologies S.A. American Depositary Shares

$11.010-0.500 (-4.344%)

Reaalajas hind

Healthcare
Biotehnoloogia
Prantsusmaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$11.510

Kõrge

$11.510

Madal

$11.010

Maht

0.02M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

301.1M

Tööstusharu

Biotehnoloogia

Riik

France

Kauplemisstatistika

Keskmine maht

0.07M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $0.441Praegune $11.010Kõrge $12.78

Seotud uudised

Analyst Upgrades

JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $21 Price Target

JMP Securities analyst Jonathan Wolleben reiterates DBV Technologies with a Market Outperform and maintains $21 price target.

Vaata rohkem
JMP Securities Reiterates Market Outperform on DBV Technologies, Maintains $21 Price Target
GlobeNewswire

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory

Vaata rohkem
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2025

Châtillon, France, June 12, 2025 DBV Technologies to Participate in Upcoming EAACI Congress 2025 DBV Technologies (TRQX:DBVp), a clinical-stage biopharmaceutical company, today announced upcoming participation in the

Vaata rohkem
DBV Technologies to Participate in Upcoming EAACI Congress 2025
GlobeNewswire

DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Châtillon, France, June 11, 2025 DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (TRQX:DBVp), a clinical-stage

Vaata rohkem
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.